{"nct_id":"NCT02122861","title":"Phase 1 Study of Intradermal LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1","status":"COMPLETED","status_verified_date":"2019-03","start_date":"2014-05-30","start_date_type":"ACTUAL","primary_completion_date":"2018-11-14","primary_completion_date_type":"ACTUAL","completion_date":"2018-12-15","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}